Cardiome Provides U.S. Regulatory Update For BRINAVESS
Go back to Cardiome Provides U.S. Regulatory Update For BRINAVESS| Impreso, Inc. (NYSE: COM) | Delayed: 33.15 -0.04 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.19 | 52 Week High | $0.60 | |||
| Open | $33.05 | 52 Week Low | $0.60 | |||
| Day High | $33.16 | P/E | N/A | |||
| Day Low | $33.05 | EPS | $-0.26 | |||
| Volume | 127,919 | |||||
| CARDIOME PHARMA (NASDAQ: CRME) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $9.21 | |||
| Open | $28.95 | 52 Week Low | $2.35 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $0.00 | |||
| Volume | 525 | |||||
